StocksMarket.in

Tag "Windlas"

 Breaking News

Windlas Biotech Standalone June 2021 Net Sales at Rs 110.96 crore, up 8.49% Y-o-Y

September 09, 2021 / 08:56 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else

Read Full Article

Windlas Biotech IPO#39;s weak debut: Shares list at 5% discount to issue price

The pharma company has mobilised Rs 401.53 crore through its public issue that was subscribed 22.47 percent during August 4-6 on account of strong response from investors. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]);

Read Full Article

Windlas Biotech listing disappoints, Exxaro Tiles jumps 10%: What should investors do now?

Most experts Moneycontrol spoke to advise holding Windlas Biotech shares for the long term while short-term investors can book profits. As for Exxaro, the advise booking profits. Sunil Shankar Matkar

Read Full Article

Buzzing Stocks: Exxaro Tiles, Windlas Biotech, Lupin and other stocks in news today

Stocks In the News: Check out the companies making the biggest headlines before the opening bell. Exxaro Tiles | Plutus Wealth Management LLP sold 2,57,235 equity shares in the company

Read Full Article

Windlas Biotech shares settle with 11.6% loss to issue price in debut trade

Cumulatively, Windlas Biotech traded with volume of 44.3 lakh equity shares on the BSE and NSE. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’]

Read Full Article

Windlas Biotech IPO oversubscribed by 22.47 times, QIB portion booked 24.4 times on final day

Windlas Biotech IPO: Investors in the grey market traded shares of Windlas Biotech at a premium of Rs 90-110, the IPO Watch and IPO Central data showed. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]);

Read Full Article

Windlas Biotech IPO: Retails investors lead charge, issue subscribed 7.06 times on Day 2

Windlas Biotech shares were trading at a premium of Rs 110-130 in the grey market, translating into a 23.9-28.3 percent

Read Full Article

Subscribe to Windlas Biotech: Prabhudas Lilladher

Prabhudas Lilladher has come out with its report on Windlas Biotech. The research firm has recommended to ”Subscribe” the ipo

Read Full Article

Windlas Biotech IPO: 10 key things to know before the issue opens

Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations CDMOs in terms of revenue, with focus

Read Full Article

Windlas Biotech IPO: Price band fixed at Rs 448-460, to raise Rs 401.53 crore

Windlas Biotech, the domestic pharmaceutical formulations contract development and manufacturing organization, has fixed the price band at Rs 448-460 per

Read Full Article

Archives